Radiology Business

APRIL 6, 2023

The Facilitating Innovative Nuclear Diagnostics Act of 2023 would eliminate barriers to nuclear medicine, supporters charged.

Nuclear Medicine 98

Nuclear Medicine Diagnostic Imaging Diagnostic Medicare 98

AuntMinnie

OCTOBER 17, 2024

The delayed restart of a nuclear research reactor in the Netherlands is expected to cause supply shortages of the imaging agent technetium-99 m (Tc-99m) into November, according to reports. “We According to estimates, Tc-99m is used in 40,000 diagnostic imaging scans in the U.S. domestic supplies of Mo-99.

Nuclear Medicine 128

Nuclear Medicine Government Diagnostic Imaging Hospital 128

AuntMinnie

JUNE 3, 2024

Eliot Siegel, MD; Stanislav Spiridonov, MD; Nathan Gee, MD; and Anthony Chang, PhD, are among a niche gathering of early adopters, entrepreneurial physicians, medical physicists, and investors with a sweet spot for nuclear medicine, diagnostic radiology, and radiation oncology.

Nuclear Medicine 105

Nuclear Medicine Radiopharmaceuticals Radiation Radiation Oncology 105

Diagnostic Imaging

JUNE 27, 2023

Nadel was announced as president of SNMMI for the 2023-2024 term at the 2023 SNMMI annual meeting taking place in Chicago.

Nuclear Medicine 98

Nuclear Medicine Imaging 98

AuntMinnie

OCTOBER 25, 2024

An assistant professor of radiology and radiological science, Francis Deng, MD, is the Johns Hopkins radiology department's co-director of medical student diagnostic radiology electives. His area of expertise is neuroradiology, with a special emphasis on diagnostic imaging of the head, neck, brain, and spine. Elliot Fishman, MD.

Nuclear Medicine 143

Nuclear Medicine Education Radiology Technologist Radiation Science 143

Imaging Technology

JUNE 10, 2024

Anderson , PhD, a trailblazer in nuclear medicine, has been named the 2024 recipient of the Georg Charles de Hevesy Nuclear Pioneer Award. The award was announced by the Society of Nuclear Medicine and Molecular Imaging (SNMMI) during its 2024 Annual Meeting, June 8-11 in Toronto.

Nuclear Medicine 104

Nuclear Medicine Radiopharmaceuticals Disease Imaging 104

AuntMinnie

JULY 12, 2024

As nuclear medicine therapies gain stature compared to nuclear medicine in diagnostic imaging, hospital administrators may be eyeing the potential of adding theranostics services. Image courtesy of Washington University. "We This oversight has led to program launch setbacks, Beyder explained.

Nuclear Medicine 105

Nuclear Medicine Radiation Oncology Radiopharmaceuticals Radiation 105

AuntMinnie

OCTOBER 30, 2024

Normal supplies of molybdenum-99 are expected to be available by the beginning of the week of November 11, according to the Society of Nuclear Medicine and Molecular Imaging (SNMMI). According to estimates, Tc-99m is used in 40,000 diagnostic imaging scans in the U.S. per day, a majority in nuclear cardiology.

Nuclear Medicine 52

Nuclear Medicine Diagnostic Imaging Hospital Diagnostic 52

AuntMinnie

MARCH 26, 2024

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. This drug relies on a gallium Ga-68, too, as a diagnostic imaging agent.

Nuclear Medicine 122

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 122

Diagnostic Imaging

OCTOBER 21, 2024

Designed for theranostic imaging applications, the AnyScan Trio SPECT/CT TheraMax scanner was recently unveiled at the annual meeting of the European Association of Nuclear Medicine (EANM).

Nuclear Medicine 61

Nuclear Medicine Imaging 61

Diagnostic Imaging

JUNE 8, 2024

The use of 90Y-FAPI-46 radioligand therapy resulted in controlled disease progression in nearly half of a 30-person cohort largely comprised of patients with advanced sarcomas, according to new research presented at the 2024 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting.

Nuclear Medicine 110

Nuclear Medicine Disease Imaging 110

Imaging Technology

JULY 9, 2024

“I am excited and honored to assume the role of CEO at Blue Earth Diagnostics,” said Campione in the written statement released today. Blue Earth Diagnostics, an indirect subsidiary of Bracco Imaging S.p.A., Blue Earth Diagnostics, an indirect subsidiary of Bracco Imaging S.p.A., Bracco Imaging S.p.A.,

Diagnostic 105

Diagnostic Radiopharmaceuticals Nuclear Medicine Magnetic Resonance Imaging 105

AuntMinnie

OCTOBER 21, 2024

A new PET/CT radiotracer that detects insulinomas could eliminate the need for other diagnostic procedures in a vast majority of patients, according to a study published October 17 in the Journal of Nuclear Medicine. Image available for republishing under Creative Commons license (CC BY 4.0 DEED, Attribution 4.0

Nuclear Medicine 111

Nuclear Medicine Imaging Modalities MRI Ultrasound 111

Diagnostic Imaging

JUNE 28, 2024

While radiologists interpreted approximately 99 percent of all non-cardiac CT, MRI and nuclear medicine studies in hospital and emergency department settings for Medicare beneficiaries, new research shows significantly less radiologist review of cardiac imaging and office-based imaging.

Medicare 101

Medicare Nuclear Medicine Radiologist Imaging 101

Imaging Technology

NOVEMBER 25, 2023

Mirion Dosimetry Services joins Sun Nuclear, Capintec, and Biodex medical imaging brands in the Mirion Medical booth (#6328) at RSNA, which will feature products and services for occupational dosimetry, diagnostic imaging QA, nuclear medicine, and medical imaging tables and accessories.

Nuclear Medicine 105

Nuclear Medicine Medical DICOM Radiology 105

Diagnostic Imaging

SEPTEMBER 18, 2023

Twice-a-day consumption of reconstituted grape powder provides significant long-term benefit in preserving cerebral metabolism for people with mild cognitive decline, according to research presented at the recent Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.

Nuclear Medicine 130

Nuclear Medicine Imaging 130

Diagnostic Imaging

NOVEMBER 6, 2023

Two experts review SNMMI (Society of Nuclear Medicine and Molecular Imaging) guidelines for use of PSMA PET scans in prostate cancer detection, as well as awareness about this new modality within the patient community.

PET Scan 110

PET Scan Nuclear Medicine Imaging 110

Diagnostic Imaging

SEPTEMBER 7, 2023

The PSMA PET agent 64Cu SAR-bisPSMA detected a higher number of prostate cancer lesions and had a significantly higher SUVmax and SUVmean than 68Ga PSMA-11 PET/CT, according to initial data from a prospective multisite study presented at the recent Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference.

Nuclear Medicine 122

Nuclear Medicine Imaging 122

Imaging Technology

JUNE 25, 2023

The new slate of officers was introduced during the Society of Nuclear Medicine and Molecular Imaging’s 2023 Annual Meeting, held June 24-27. The new slate of officers was introduced during the Society of Nuclear Medicine and Molecular Imaging’s 2023 Annual Meeting, held June 24-27. “I

Nuclear Medicine 52

Nuclear Medicine Education Diagnostic Imaging Patient Care 52

Diagnostic Imaging

JUNE 25, 2023

In a lecture at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference, Matthew F. Covington, M.D., discussed key findings from recent studies that emphasize the possible prognostic role of positron emission tomography (PET) in de-escalating treatment for breast cancer.

Nuclear Medicine 112

Nuclear Medicine Imaging 112

Diagnostic Imaging

JUNE 26, 2023

A new modality that provides high-dose, molecularly targeted radiation to hematopoietic cells allows bone marrow transplant in patients with relapsed or refractory acute myeloid leukemia (AML) and may double one-year survival rates in comparison to conventional care, according to new research that garnered “Abstract of the Year” honors at the Society (..)

Radiation 119

Radiation Nuclear Medicine Imaging 119

Diagnostic Imaging

JUNE 8, 2024

For patients with interstitial lung disease, FAPI PET/CT was more effective than 18F-FDG PET/CT at predicting progressive pulmonary fibrosis according to comparative study findings presented at the 2024 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting.

Nuclear Medicine 66

Nuclear Medicine Disease Imaging 66

AuntMinnie

JUNE 20, 2024

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. This drug relies on a gallium Ga-68, too, as a diagnostic imaging agent.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 52

Diagnostic Imaging

AUGUST 3, 2023

The PET radiotracer 18F-PSMA-1007 facilitated detection of at least one suspicious lesion for metastasis in nearly half of a cohort of 160 patients with prostate cancer, according to research presented recently at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.

Nuclear Medicine 98

Nuclear Medicine Imaging 98

Diagnostic Imaging

AUGUST 17, 2023

percent cancer detection rate in comparison to 80 percent for multiparametric MRI, according to research presented at the recent Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.

Nuclear Medicine 98

Nuclear Medicine MRI Imaging 98

TTG Imaging Solutions

AUGUST 1, 2023

Martin Shirley was appointed the role of TTG Imaging Solutions Executive Vice President Sales, Marketing & Clinical Operations in April of 2023 as part of TTG Imaging Solutions acquisition of Digirad Health, Inc and its subsidiaries Digirad Diagnostic Imaging, Inc and Digirad Imaging Solution, Inc.

Nuclear Medicine 40

Nuclear Medicine Clinic Radiopharmaceuticals Diagnostic Imaging 40

TTG Imaging Solutions

AUGUST 1, 2023

Martin Shirley was appointed the role of TTG Imaging Solutions Executive Vice President Sales, Marketing & Clinical Operations in April of 2023 as part of TTG Imaging Solutions acquisition of Digirad Health, Inc and its subsidiaries Digirad Diagnostic Imaging, Inc and Digirad Imaging Solution, Inc.

Nuclear Medicine 40

Nuclear Medicine Clinic Radiopharmaceuticals Diagnostic Imaging 40

Diagnostic Imaging

JUNE 29, 2023

In an interview at the recent Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference in Chicago, Jeremie Calais, M.D., MSc discussed promising research findings for the use of the positron emission tomography (PET) imaging agent 89ZR-DFO-girentuximab for diagnosing clear cell renal cell carcinoma.

Nuclear Medicine 91

Nuclear Medicine Imaging Diagnose 91

Diagnostic Imaging

SEPTEMBER 28, 2023

percent incidence of bone-only metastasis in a cohort of men with castration-resistant prostate cancer, according to findings from research presented at the recent Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference. Researchers noted a 20.1

Nuclear Medicine 77

Nuclear Medicine Imaging 77

AuntMinnie

MARCH 29, 2024

The investigators sought to assess imaging spending among the ESI population via a study that consisted of information from the 2010 to 2021 Merative MarketScan Commercial Database that included 33.9 million individuals; they used the Neiman Imaging Types of Services (NITOS), version 4.0 Nuclear medicine 2.7%

Healthcare 116

Healthcare Healthcare Nuclear Medicine Imaging 116

Diagnostic Imaging

AUGUST 8, 2023

discussed retrospective research, presented at the recent Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference, that evaluated the combination of artificial intelligence (AI)-based software and the PSMA agent piflufolastat F 18 to help quantify prostate cancer lesions and associations with biochemical progression-free survival.

Nuclear Medicine 78

Nuclear Medicine Imaging 78

Diagnostic Imaging

SEPTEMBER 20, 2023

percent for diagnosing clear cell renal cell carcinoma, according to research recently presented at the European Association of Nuclear Medicine (EANM) 2023 Congress. For cT1 renal masses < 4 cm and renal masses < 2 cm, the PET/CT agent 89Zr-DFO-girentuximab had respective sensitivity rates of approximately 85 percent and 96.7

Nuclear Medicine 72

Nuclear Medicine Diagnose 72

Imaging Technology

OCTOBER 11, 2023

milla1cf Wed, 10/11/2023 - 13:08 October 11, 2023 — A new imaging agent, 68Ga-ABY-025 , can predict early metabolic response to human epidermal growth factor receptor 2 ( HER2 )-targeted treatment in HER2-positive metastatic breast cancer patients, according to new research published in the September issue of The Journal of Nuclear Medicine.

Nuclear Medicine 111

Nuclear Medicine Disease Diagnostic Imaging Imaging 111

Imaging Technology

JUNE 12, 2024

Offering the full modality of diagnostic scans, including 3T MRI, CT, ultrasound, 3-D mammography, PET/CT, nuclear medicine, DEXA, X-rays, among others, the company uses the newest, most advanced, diagnostic imaging technologies while maintaining affordability and accessibility.

Disease 116

Disease Magnetic Resonance Imaging Nuclear Medicine Imaging 116

Diagnostic Imaging

JUNE 28, 2023

New research presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference suggests that neuroreceptor differences in reactions to visual food cues between obese people and normal-weight individuals may improve the understanding of underlying mechanisms that contribute to obesity.

Nuclear Medicine 63

Nuclear Medicine Imaging 63

Capitol Imaging Services

JANUARY 6, 2022

If further testing is needed, Diagnostic Imaging Services has multiple options available such as: Ultrasound An ultrasound can determine if a lump in the neck is from the thyroid or another structure, if the nodule looks cancerous, or if a nodule has grown in size.

Disease 52

Disease Nuclear Medicine Ultrasound Diagnostic Imaging 52

TTG Imaging Solutions

SEPTEMBER 28, 2021

Be sure to visit us at our virtual booth Thursday, September 30 through Saturday, October 2 to learn more about our complete nuclear medicine and molecular imaging solutions. For the latest updates on TTG Imaging Solutions, connect with us on LinkedIn , Twitter , and Facebook.

Nuclear Medicine 52

Nuclear Medicine Imaging Radiopharmaceuticals Diagnostic Imaging 52